INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

PR Newswire

NEW YORK, Aug. 6, 2025

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether NeoGenomics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

July 29, 2025 , NeoGenomics issued a press release reporting its financial results for the second quarter of 2025. Among other items, NeoGenomics reported revenue of $181.3 million , falling short of consensus estimates, and a net loss of $45.1 million . NeoGenomics also reduced its 2025 revenue forecast to a range of $720 million to $726 million , down from a previous estimate of approximately $753 million . In addition, NeoGenomics lowered its adjusted EBITDA projection to a range of $41 million to $44 million from a prior range of $55 million to $58 million . 

On this news, NeoGenomics' stock price fell $1.21 per share, or 18.73%, to close at $5.25 per share on July 29, 2025 .

Pomerantz LLP, with offices in New York , Chicago , Los Angeles , London , Paris , and Tel Aviv , is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud , breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See  www.pomlaw.com .

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-neogenomics-inc---neo-302523720.html

SOURCE Pomerantz LLP

Läs mer på PR Newswire

Ämnen i artikeln

NeoGenomics

Senast

5,70

1 dag %

3,83%

1 dag

1 mån

1 år

Marknadsöversikt

OMX Stockholm 30

1 DAG %

0,36%

Senast

2 602,98

1 mån
Loading market data...
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.